Why Aren’t We Connecting?
Digital technology is all around us, but pharma isn’t quite getting it right… yet.
Kal Patel |
Healthcare today is largely disconnected, particularly when it comes to pharma’s involvement. Only a tiny percentage of the potential information and relevant data that can be collected about patients is collected – and until pharma companies start collecting and harnessing this data, they will continue to live in a world of ignorance. As an example, consider this; a pharma company spends nearly $2 billion and takes over ten years to develop an innovative drug to treat an unmet medical need, which subsequently receives regulatory approval and reimbursement. The physician writes a prescription which passes through the system, but the only data that goes back to the practitioner, pharma company, or anybody else in the healthcare system, is whether the patient picked up their prescription. There is no information about whether the patient actually took the drug correctly and for the full term (unlikely), whether it worked, or whether it had side effects (with the exception of extreme cases). If more data could be collected, it would shed a lot of light on how the product and patient experience can be further improved, which should, in turn, improve patient adherence and outcomes.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.